Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 192


Molecular determinants of drug response in TNBC cell lines.

Merrill NM, Lachacz EJ, Vandecan NM, Ulintz PJ, Bao L, Lloyd JP, Yates JA, Morikawa A, Merajver SD, Soellner MB.

Breast Cancer Res Treat. 2019 Oct 26. doi: 10.1007/s10549-019-05473-9. [Epub ahead of print]


Breast cancers utilize hypoxic glycogen stores via PYGB, the brain isoform of glycogen phosphorylase, to promote metastatic phenotypes.

Altemus MA, Goo LE, Little AC, Yates JA, Cheriyan HG, Wu ZF, Merajver SD.

PLoS One. 2019 Sep 19;14(9):e0220973. doi: 10.1371/journal.pone.0220973. eCollection 2019.


IL-4/IL-13 Stimulated Macrophages Enhance Breast Cancer Invasion Via Rho-GTPase Regulation of Synergistic VEGF/CCL-18 Signaling.

Little AC, Pathanjeli P, Wu Z, Bao L, Goo LE, Yates JA, Oliver CR, Soellner MB, Merajver SD.

Front Oncol. 2019 May 31;9:456. doi: 10.3389/fonc.2019.00456. eCollection 2019.


Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa.

Schairer C, Hablas A, Eldein IAS, Gaafar R, Rais H, Mezlini A, Ayed FB, Ayoub WB, Benider A, Tahri A, Khouchani M, Aboulazm D, Karkouri M, Eissa S, Pfeiffer RM, Gadalla SM, Swain SM, Merajver SD, Brown LM, Soliman AS.

Breast Cancer Res Treat. 2019 Jul;176(2):407-417. doi: 10.1007/s10549-019-05237-5. Epub 2019 Apr 22.


A platform for artificial intelligence based identification of the extravasation potential of cancer cells into the brain metastatic niche.

Oliver CR, Altemus MA, Westerhof TM, Cheriyan H, Cheng X, Dziubinski M, Wu Z, Yates J, Morikawa A, Heth J, Castro MG, Leung BM, Takayama S, Merajver SD.

Lab Chip. 2019 Mar 27;19(7):1162-1173. doi: 10.1039/c8lc01387j.


Clinical characteristics, HIV status, and molecular biomarkers in squamous cell carcinoma of the conjunctiva in Ghana.

Merz LE, Afriyie O, Jiagge E, Adjei E, Foltin SK, Ludwig ML, McHugh JB, Brenner JC, Merajver SD.

Health Sci Rep. 2019 Jan 10;2(2):e108. doi: 10.1002/hsr2.108. eCollection 2019 Feb.


Biophysical Phenotyping and Modulation of ALDH+ Inflammatory Breast Cancer Stem-Like Cells.

Chen W, Allen SG, Qian W, Peng Z, Han S, Li X, Sun Y, Fournier C, Bao L, Lam RHW, Merajver SD, Fu J.

Small. 2019 Feb;15(5):e1802891. doi: 10.1002/smll.201802891. Epub 2019 Jan 11.


Correction: Expression of immunohistochemical markers in non-oropharyngeal head and neck squamous cell carcinoma in Ghana.

Owusu-Afriyie O, Owiredu WKBA, Owusu-Danquah K, Komarck C, Foltin SK, Larsen-Reindorf R, Acheampong E, Quayson SE, Prince ME, McHugh JB, Donkor P, Merajver SD, Brenner JC.

PLoS One. 2018 Dec 19;13(12):e0209696. doi: 10.1371/journal.pone.0209696. eCollection 2018.


Disparities in genetic services utilization in a random sample of young breast cancer survivors.

Nikolaidis C, Duquette D, Mendelsohn-Victor KE, Anderson B, Copeland G, Milliron KJ, Merajver SD, Janz NK, Northouse LL, Duffy SA, Katapodi MC.

Genet Med. 2019 Jun;21(6):1363-1370. doi: 10.1038/s41436-018-0349-1. Epub 2018 Nov 2.


Synergistic inhibition of aggressive breast cancer cell migration and invasion by cytoplasmic delivery of anti-RhoC silencing RNA and presentation of EPPT1 peptide on "smart" particles.

Kaushal N, Tiruchinapally G, Durmaz YY, Bao L, Gilani R, Merajver SD, ElSayed MEH.

J Control Release. 2018 Nov 10;289:79-93. doi: 10.1016/j.jconrel.2018.07.042. Epub 2018 Aug 24.


Expression of immunohistochemical markers in non-oropharyngeal head and neck squamous cell carcinoma in Ghana.

Owusu-Afriyie O, Owiredu WKBA, Owusu-Danquah K, Komarck C, Foltin SK, Larsen-Reindorf R, Acheampong E, Quayson SE, Prince MEP, McHugh JB, Donkor P, Merajver SD, Brenner JC.

PLoS One. 2018 Aug 23;13(8):e0202790. doi: 10.1371/journal.pone.0202790. eCollection 2018. Erratum in: PLoS One. 2018 Dec 19;13(12):e0209696.


Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling.

Luo M, Shang L, Brooks MD, Jiagge E, Zhu Y, Buschhaus JM, Conley S, Fath MA, Davis A, Gheordunescu E, Wang Y, Harouaka R, Lozier A, Triner D, McDermott S, Merajver SD, Luker GD, Spitz DR, Wicha MS.

Cell Metab. 2018 Jul 3;28(1):69-86.e6. doi: 10.1016/j.cmet.2018.06.006.


Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary Conference.

Woodward WA, Cristofanilli M, Merajver SD, Van Laere S, Pusztai L, Bertucci F, Berditchevski F, Polyak K, Overmoyer B, Devi GR, Sterneck E, Schneider R, Debeb BG, Wang X, van Golen KL, El-Zein R, Rahal OM, Alexander A, Reuben JM, Krishnamurthy S, Lucci A, Ueno NT.

J Cancer. 2017 Oct 9;8(17):3607-3614. doi: 10.7150/jca.21200. eCollection 2017.


Development of a Web-based Family Intervention for BRCA Carriers and Their Biological Relatives: Acceptability, Feasibility, and Usability Study.

Katapodi MC, Jung M, Schafenacker AM, Milliron KJ, Mendelsohn-Victor KE, Merajver SD, Northouse LL.

JMIR Cancer. 2018 Apr 13;4(1):e7. doi: 10.2196/cancer.9210.


Loss of PTEN promotes formation of signaling-capable clathrin-coated pits.

Rosselli-Murai LK, Yates JA, Yoshida S, Bourg J, Ho KKY, White M, Prisby J, Tan X, Altemus M, Bao L, Wu ZF, Veatch SL, Swanson JA, Merajver SD, Liu AP.

J Cell Sci. 2018 Apr 26;131(8). pii: jcs208926. doi: 10.1242/jcs.208926.


Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa.

Hadgu E, Seifu D, Tigneh W, Bokretsion Y, Bekele A, Abebe M, Sollie T, Merajver SD, Karlsson C, Karlsson MG.

BMC Womens Health. 2018 Feb 14;18(1):40. doi: 10.1186/s12905-018-0531-2.


Surveillance for cancer recurrence in long-term young breast cancer survivors randomly selected from a statewide cancer registry.

Jones T, Duquette D, Underhill M, Ming C, Mendelsohn-Victor KE, Anderson B, Milliron KJ, Copeland G, Janz NK, Northouse LL, Duffy SM, Merajver SD, Katapodi MC.

Breast Cancer Res Treat. 2018 May;169(1):141-152. doi: 10.1007/s10549-018-4674-5. Epub 2018 Jan 20.


Breast Cancer in Ghana: Demonstrating the Need for Population-Based Cancer Registries in Low- and Middle-Income Countries.

Thomas AS, Kidwell KM, Oppong JK, Adjei EK, Osei-Bonsu E, Boahene A, Jiggae E, Gyan K, Merajver SD.

J Glob Oncol. 2017 Dec;3(6):765-772. doi: 10.1200/JGO.2016.006098. Epub 2017 Mar 27.


Tracking the tumor invasion front using long-term fluidic tumoroid culture.

Aw Yong KM, Li Z, Merajver SD, Fu J.

Sci Rep. 2017 Sep 7;7(1):10784. doi: 10.1038/s41598-017-10874-1.


Mechanotransduction-Induced Reversible Phenotypic Switching in Prostate Cancer Cells.

Aw Yong KM, Sun Y, Merajver SD, Fu J.

Biophys J. 2017 Mar 28;112(6):1236-1245. doi: 10.1016/j.bpj.2017.02.012.


Reliability of medical records in diagnosing inflammatory breast cancer in Egypt.

Le L, Schairer C, Hablas A, Meza J, Watanabe-Galloway S, Ramadan M, Merajver SD, Seifeldin IA, Soliman AS.

BMC Res Notes. 2017 Mar 16;10(1):126. doi: 10.1186/s13104-017-2433-z.


Recruiting families at risk for hereditary breast and ovarian cancer from a statewide cancer registry: a methodological study.

Katapodi MC, Duquette D, Yang JJ, Mendelsohn-Victor K, Anderson B, Nikolaidis C, Mancewicz E, Northouse LL, Duffy S, Ronis D, Milliron KJ, Probst-Herbst N, Merajver SD, Janz NK, Copeland G, Roberts S.

Cancer Causes Control. 2017 Mar;28(3):191-201. doi: 10.1007/s10552-017-0858-2. Epub 2017 Feb 14.


NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.

Daly MB, Pilarski R, Berry M, Buys SS, Farmer M, Friedman S, Garber JE, Kauff ND, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Merajver SD, Offit K, Pal T, Reiser G, Shannon KM, Swisher E, Vinayak S, Voian NC, Weitzel JN, Wick MJ, Wiesner GL, Dwyer M, Darlow S.

J Natl Compr Canc Netw. 2017 Jan;15(1):9-20.


Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling.

Allen SG, Chen YC, Madden JM, Fournier CL, Altemus MA, Hiziroglu AB, Cheng YH, Wu ZF, Bao L, Yates JA, Yoon E, Merajver SD.

Sci Rep. 2016 Dec 19;6:39190. doi: 10.1038/srep39190.


Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer.

Cobain EF, Milliron KJ, Merajver SD.

Semin Oncol. 2016 Oct;43(5):528-535. doi: 10.1053/j.seminoncol.2016.10.001. Epub 2016 Oct 8. Review.


Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics.

Chen W, Allen SG, Reka AK, Qian W, Han S, Zhao J, Bao L, Keshamouni VG, Merajver SD, Fu J.

BMC Cancer. 2016 Aug 8;16:614. doi: 10.1186/s12885-016-2638-x.


Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer.

Jiagge E, Jibril AS, Chitale D, Bensenhaver JM, Awuah B, Hoenerhoff M, Adjei E, Bekele M, Abebe E, Nathanson SD, Gyan K, Salem B, Oppong J, Aitpillah F, Kyei I, Bonsu EO, Proctor E, Merajver SD, Wicha M, Stark A, Newman LA.

Ann Surg Oncol. 2016 Nov;23(12):3843-3849. Epub 2016 Jul 28.


Chronic Mastitis in Egypt and Morocco: Differentiating between Idiopathic Granulomatous Mastitis and IgG4-Related Disease.

Allen SG, Soliman AS, Toy K, Omar OS, Youssef T, Karkouri M, Ayad E, Abdel-Aziz A, Hablas A, Tahri A, Oltean HN, Kleer CG, Merajver SD.

Breast J. 2016 Sep;22(5):501-9. doi: 10.1111/tbj.12628. Epub 2016 Jun 8.


The Impact of Nathan Mantel's "The Detection of Disease Clustering and a Generalized Regression Approach".

Wynn M, Kidwell KM, Merajver SD.

Cancer Res. 2016 May 1;76(9):2495-6. doi: 10.1158/0008-5472.CAN-16-0883. No abstract available.


UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer.

Gilani RA, Phadke S, Bao LW, Lachacz EJ, Dziubinski ML, Brandvold KR, Steffey ME, Kwarcinski FE, Graveel CR, Kidwell KM, Merajver SD, Soellner MB.

Clin Cancer Res. 2016 Oct 15;22(20):5087-5096. Epub 2016 May 6.


Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes.

Kang Q, Henry NL, Paoletti C, Jiang H, Vats P, Chinnaiyan AM, Hayes DF, Merajver SD, Rae JM, Tewari M.

Clin Biochem. 2016 Dec;49(18):1354-1360. doi: 10.1016/j.clinbiochem.2016.03.012. Epub 2016 Apr 27.


RhoC GTPase Is a Potent Regulator of Glutamine Metabolism and N-Acetylaspartate Production in Inflammatory Breast Cancer Cells.

Wynn ML, Yates JA, Evans CR, Van Wassenhove LD, Wu ZF, Bridges S, Bao L, Fournier C, Ashrafzadeh S, Merrins MJ, Satin LS, Schnell S, Burant CF, Merajver SD.

J Biol Chem. 2016 Jun 24;291(26):13715-29. doi: 10.1074/jbc.M115.703959. Epub 2016 Apr 25.


Effects of postpartum mobile phone-based education on maternal and infant health in Ecuador.

Maslowsky J, Frost S, Hendrick CE, Trujillo Cruz FO, Merajver SD.

Int J Gynaecol Obstet. 2016 Jul;134(1):93-8. doi: 10.1016/j.ijgo.2015.12.008. Epub 2016 Apr 8.


Use of Cancer Genetics Services in African-American Young Breast Cancer Survivors.

Jones T, Lockhart JS, Mendelsohn-Victor KE, Duquette D, Northouse LL, Duffy SA, Donley R, Merajver SD, Milliron KJ, Roberts JS, Katapodi MC.

Am J Prev Med. 2016 Oct;51(4):427-36. doi: 10.1016/j.amepre.2016.03.016. Epub 2016 Apr 23.


Clinical predictors of long-term survival in HER2-positive metastatic breast cancer.

Murthy P, Kidwell KM, Schott AF, Merajver SD, Griggs JJ, Smerage JD, Van Poznak CH, Wicha MS, Hayes DF, Henry NL.

Breast Cancer Res Treat. 2016 Feb;155(3):589-95. doi: 10.1007/s10549-016-3705-3. Epub 2016 Feb 13.


Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.

Daly MB, Pilarski R, Axilbund JE, Berry M, Buys SS, Crawford B, Farmer M, Friedman S, Garber JE, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Rana H, Reiser G, Robson ME, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan A, Wick MJ, Wiesner GL, Dwyer M, Kumar R, Darlow S.

J Natl Compr Canc Netw. 2016 Feb;14(2):153-62.


Triple-Negative Breast Cancer in Ghanaian Women: The Korle Bu Teaching Hospital Experience.

Der EM, Gyasi RK, Tettey Y, Edusei L, Bayor MT, Jiagge E, Gyakobo M, Merajver SD, Newman LA.

Breast J. 2015 Nov-Dec;21(6):627-33. doi: 10.1111/tbj.12527.


Breast cancer by age at diagnosis in the Gharbiah, Egypt, population-based registry compared to the United States Surveillance, Epidemiology, and End Results Program, 2004-2008.

Schlichting JA, Soliman AS, Schairer C, Harford JB, Hablas A, Ramadan M, Seifeldin I, Merajver SD.

Biomed Res Int. 2015;2015:381574. doi: 10.1155/2015/381574. Epub 2015 Oct 1.


Cancer classification in the genomic era: five contemporary problems.

Song Q, Merajver SD, Li JZ.

Hum Genomics. 2015 Oct 19;9:27. doi: 10.1186/s40246-015-0049-8. Review.


Breast Cancer Risk Reduction, Version 2.2015.

Bevers TB, Ward JH, Arun BK, Colditz GA, Cowan KH, Daly MB, Garber JE, Gemignani ML, Gradishar WJ, Jordan JA, Korde LA, Kounalakis N, Krontiras H, Kumar S, Kurian A, Laronga C, Layman RM, Loftus LS, Mahoney MC, Merajver SD, Meszoely IM, Mortimer J, Newman L, Pritchard E, Pruthi S, Seewaldt V, Specht MC, Visvanathan K, Wallace A, Bergman MA, Kumar R.

J Natl Compr Canc Netw. 2015 Jul;13(7):880-915.


"Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.

Kaushal N, Durmaz YY, Bao L, Merajver SD, ElSayed ME.

Mol Pharm. 2015 Jul 6;12(7):2406-17. doi: 10.1021/acs.molpharmaceut.5b00114. Epub 2015 May 28.


Single-cell Migration Chip for Chemotaxis-based Microfluidic Selection of Heterogeneous Cell Populations.

Chen YC, Allen SG, Ingram PN, Buckanovich R, Merajver SD, Yoon E.

Sci Rep. 2015 May 18;5:9980. doi: 10.1038/srep09980.


Inferring the Effects of Honokiol on the Notch Signaling Pathway in SW480 Colon Cancer Cells.

Wynn ML, Consul N, Merajver SD, Schnell S.

Cancer Inform. 2014 Oct 13;13(Suppl 5):1-12. doi: 10.4137/CIN.S14060. eCollection 2014.


Factors related to incomplete treatment of breast cancer in Kumasi, Ghana.

Obrist M, Osei-Bonsu E, Awuah B, Watanabe-Galloway S, Merajver SD, Schmid K, Soliman AS.

Breast. 2014 Dec;23(6):821-8. doi: 10.1016/j.breast.2014.08.014. Epub 2014 Oct 1.


Genetic/familial high-risk assessment: breast and ovarian, version 1.2014.

Daly MB, Pilarski R, Axilbund JE, Buys SS, Crawford B, Friedman S, Garber JE, Horton C, Kaklamani V, Klein C, Kohlmann W, Kurian A, Litton J, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Pasche B, Reiser G, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan A, Wiesner GL, Dwyer MA, Kumar R; National comprehensive cancer network.

J Natl Compr Canc Netw. 2014 Sep;12(9):1326-38.


Characterizing breast cancer treatment pathways in Kumasi, Ghana from onset of symptoms to final outcome: outlook towards cancer control.

Scherber S, Soliman AS, Awuah B, Osei-Bonsu E, Adjei E, Abantanga F, Merajver SD.

Breast Dis. 2014 Jan 1;34(4):139-49. doi: 10.3233/BD-140372.


A comparison of criteria to identify inflammatory breast cancer cases from medical records and the Surveillance, Epidemiology and End Results data base, 2007-2009.

Hirko KA, Soliman AS, Banerjee M, Ruterbusch J, Harford JB, Merajver SD, Schwartz K.

Breast J. 2014 Mar-Apr;20(2):185-91. doi: 10.1111/tbj.12234. Epub 2013 Dec 26.


Risk factors for chronic mastitis in morocco and egypt.

Oltean HN, Soliman AS, Omar OS, Youssef TF, Karkouri M, Abdel-Aziz A, Hablas A, Blachley T, Tahri A, Merajver SD.

Int J Inflam. 2013;2013:184921. doi: 10.1155/2013/184921. Epub 2013 Nov 14.


Trends in Breast Cancer Incidence Rates by Age and Stage at Diagnosis in Gharbiah, Egypt, over 10 Years (1999-2008).

Hirko KA, Soliman AS, Hablas A, Seifeldin IA, Ramadan M, Banerjee M, Harford JB, Chamberlain RM, Merajver SD.

J Cancer Epidemiol. 2013;2013:916394. doi: 10.1155/2013/916394. Epub 2013 Oct 24.

Supplemental Content

Loading ...
Support Center